Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Learn which cash rewards credit cards have no fees, allowing you to earn rewards without the financial burden. Make informed choices.
27,645 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Two leading firms cut Microsoft price targets ahead of fiscal Q4, but both retain bullish ratings as Copilot and Azur...
Real Brokerage reports 2025 revenue approaching $2 billion, signaling the strength of a platform-first approach that ...
Stocks rose Tuesday as AI momentum outweighed inflation jitters, with fresh analyst calls on Autodesk, Celanese, DexC...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
As AMD gears up for its Aug. 4 earnings release, the stock’s unstoppable momentum raises questions: what would truly ...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
Markets weigh whether will spacex’s $1.75 trillion IPO valuation can survive a Friday rout that hit growth and tech s...
SpaceX's Starlink program could redefine internet access and investor value. This year’s launch pace hinges on regula...
As the infrastructure megatrend gathers steam, a single ETF could anchor your 2026 strategy. Learn which fund stands ...